ÉúÃüѧԺÂíÈóÁÖÑо¿×éÔÚ·´Û»ÀදÎï½ø»¯Ñо¿ÖÐÈ¡µÃÖØÒª½øÕ¹
Öйú¿ÆÑ§Ôº´óѧÉúÃü¿ÆÑ§Ñ§ÔºÂíÈóÁÖ½ÌÊÚÑо¿ÍŶÓÔÚ¶¯ÎïÖ÷Òª×éÖ¯ÏàÈÝÐÔ¸´ºÏÌå(Major Histocompatibility Complex, MHC)½á¹¹Ñо¿ÖÐÈ¡µÃÖØÒª½øÕ¹£¬³õ²½½Òʾ°üÀ¨Å£ÑòÔÚÄÚµÄÈ«²¿·´Û»ÀදÎïMHCÔÚClass IIÇøÓòÄÚ´æÔÚÒ»´ó¶Î³£È¾É«Ìå²åÈ룬°ÑÔ±¾ÍêÕûµÄClass II·Ö¸îΪIIaÓëIIb£¬²¢°éËæÓе÷¿ØÃâÒßϸ°ûµÄDYÀàлùÒò²úÉú¡£Ñо¿ÈÏΪ¸ÃȾɫÌ嵹λʼþºÜ¿ÉÄÜÔ´×Ô·´Û»ÀදÎï×îºó¹²Í¬×æÏÈÉúֳϸ°û·¢ÉúµÄÒ»´ÎȾɫÌ嵹루Crossing Over£©£¬µ¹Î»´Ù½øÁË·´Û»ÀàÔÚµØÇòÉúÎïȦµÄ·±ÈÙÓëÀ©ÕÅ£¬ÑÜÉú³öʳ²ÝÀà·´Û»¶¯ÎïµÄÅÓ´óÀàȺ£¬¶Ôά³Ö×ÔÈ»½çʳÎïÁ´Éú̬ƽºâ·¢»ÓÁËÖØÒª×÷Ó᣸ÃÏîÑо¿½á¹û×î½ü·¢±íÔÚ¹ú¼ÊÃâÒßÑ§Ç°ÑØÔÓÖ¾¡¶Frontiers in Immunology¡·¡£
MHC±àÂëÒ»´óÀàÃâÒß·ÀÓùÏà¹Øµ°°×Óëµ÷¿ØÒò×Ó£¬ÊÇÈËÀàºÍËùÓв¸È鶯ÎïÃâÒßµÖ¿¹¸÷ÀàvwinµÂÓ®ÇÖȾºÍÖ²¡ÐÔ×îΪ¹Ø¼üµÄÒÅ´«»ù´¡¡£·´Û»¶¯ÎïÀûÓÃÁöθvwinµÂÓ®ÓÐЧת»¯¹Ì¶¨ÓÚËDzÝÖеÄÌ«ÑôÄÜ£¬¶ÔÓÚά³ÖµØÇò¸ßµÈÈâʳ¶¯ÎïµÄʳÎïÁ´Æðµ½Á˳ÐÉÏÆôϵĹؼü×÷Óá£ÂíÈóÁÖÑо¿×éÔÚǰÆÚÑо¿ÖÐ֤ʵ¼ÒÅ£ºÍÃàÑòMHCÇøÓòÄÚÓÐÒ»¶ÎÔ¼18 MbȾɫÌ嵹룬Ôì³ÉMHC class IIÇøÓò±»·Ö¸îΪII aºÍII bÁ½¸öÑÇÇø¡£·´Û»¶¯ÎïÌØÓеÄDY»ùÒòλÓÚµ¹Î»±ßÔµ²¢ÇÒÔÚÊ÷ͻ״ϸ°ûÖи߶ȱí´ï¡£µ«¸Ãµ¹Î»ÔÚ·´Û»¶¯ÎïÖÐÊÇ·ñ¾ßÓÐÆÕ±éÐÔÒÔ¼°¶Ô·´Û»¶¯Îï½ø»¯µÄÒâÒåÉÐÊôδ֪¡£
¾¨Å¼ÌãÄ¿×æÏÈȾɫÌ嵹λµÄ¼Ù˵
ÂíÈóÁÖÑо¿×éʹÓøßͨÁ¿²âÐò¼¼Êõ¶Ô¸²¸ÇÐý½ÇÁçMHCÇø¶ÎµÄ47¸öBAC¿Ë¡½øÐÐÖðÒ»²âÐò£¬µÃµ½ÁËÈ«³¤Îª3,224,151bpµÄ·Ö×ÓÐòÁУ¬×¢ÊÍÁË150¸ö±àÂë»ùÒò¡¢50¸ötRNA»ùÒòºÍ14¸ö·Ç±àÂëRNA»ùÒò¡£¾¹ýÐòÁбȽϷÖÎö·¢ÏÖÐý½ÇÁçMHCµÄ×éÖ¯½á¹¹ÓëÃàÑòºÍ¼ÒÅ£¸ß¶È±£ÊØ£¬¾ùÓÐ´óÆ¬¶ÎȾɫÌ嵹λµÄ´æÔÚ¡£ÏµÍ³·¢Éú·ÖÎö±íÃ÷DY»ùÒòºÍDQ»ùÒòµÄ¹ØÏµ½Ï½ü£¬¶þÕߵķ֯çʱ¼äÔÚ¾à½ñ1.4ÒÚÄêǰ¡£Í¬Ô´½¨Ä£½á¹ûÏÔʾ£¬Ðý½ÇÁçDYµÄÕûÌå½á¹¹ÓëHLA-DQ2ÏàËÆ¡£È»¶ø£¬p1¡¢p4¡¢p6ºÍp9ÕâËĸöÓ°Ï쿹ÔëĽáºÏµÄ¿Ú´üµÄÌå»ý´óС¡¢ÊèË®ÐԺ͵çºÉµÈÐÔÖÊÈ´´ó²»Ïàͬ£¬ÌáʾÐý½ÇÁçDYºÍHLA-DQ2Ëù³ÊµÝµÄ¿¹ÔëÄÖÖÀ಻ͬ£¬ÀíÂÛÉÏ¿ÉÒÔÌá¸ß·´Û»¶¯Îï¶ÔÁöθvwinµÂÓ®µÄµ÷½ÚÄÜÁ¦£¬´Ó¶øÌá¸ß·´Û»¶¯Îï¶ÔÄÁ²ÝµÄÀûÓÃÄÜÁ¦¡£ÕâÏîÑо¿³É¹û¼ÓÉîÁËÎÒÃǶÔMHCÇøÓò½ø»¯µÄÀí½â£¬²¢Îª·´Û»¶¯Îï¹²×æÏÈȾɫÌå¼Ù˵ÌṩÁ˶îÍâµÄÖ§³ÖÐÔÖ¤¾Ý£¬¼´·´Û»¶¯Îï×îºó¹²Í¬×æÏÈMHCÇøÓòµÄ¹ÅÀÏȾɫÌ嵹λ¿ÉÄÜÊǵØÇòÉÏ·´Û»¶¯Îï½ø»¯³É¹¦µÄÔÒòÖ®Ò»¡£
¸ÃÂÛÎÄÓÚ2020Äê2ÔÂ25ÈÕÔÚFrontiers in ImmunologyÔÓÖ¾ÉÏÔÚÏß·¢±í¡£ÂíÈóÁÖÑо¿×éµÄ²©Ê¿Ñо¿ÉúÀÀ¥Îª¸ÃÎÄÕµĵÚÒ»×÷Õߣ¬ÂíÈóÁÖÑо¿Ô±ÎªÍ¨Ñ¶×÷Õß¡£Ïà¹ØÑо¿µÃµ½ÖпÆÔº¹ú¼Ê»ï°é¼Æ»®ºÍ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿µÄ×ÊÖú¡£